Clinical Trial Update: Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects [Phase 3]

View source ↗

Summary

Phase 3 safety study evaluating arformoterol tartrate inhalation solution in adults with chronic obstructive pulmonary disease; the trial is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Brovana (arformoterol tartrate) inhalation solution (arformoterol tartrate)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-11-11